XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue - Remaining Performance Obligations (Details)
$ in Millions
6 Months Ended
Jun. 30, 2019
USD ($)
Diagnostic Products  
Remaining Performance Obligations  
Remaining performance obligations $ 3,100
Cardiovascular and Neuromodulation Products  
Remaining Performance Obligations  
Remaining performance obligations $ 375
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-07-01  
Remaining Performance Obligations  
Expected timing of satisfication period (in months) 24 months
Percentage of remaining performance obligation expected to be recognized in period 60.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01  
Remaining Performance Obligations  
Expected timing of satisfication period (in months) 12 months
Percentage of remaining performance obligation expected to be recognized in period 16.00%